Marco Cerrano
0000-0003-1666-3100
7 papers found
Refreshing results…
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation
Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation
Germline DDX41 mutations define a significant entity within adult MDS/AML patients
Can pegylated interferon improve the outcome of polycythemia vera patients?
Missing publications? Search for publications with a matching author name.